EMEA-002195-PIP01-17
Key facts
| Active substance |
Vonapanitase
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0368/2017
|
| PIP number |
EMEA-002195-PIP01-17
|
| Pharmaceutical form(s) |
Irrigation solution
|
| Condition(s) / indication(s) |
Prevention of arteriovenous access dysfunction
|
| Route(s) of administration |
Epilesional use
|
| Contact for public enquiries |
Proteon Therapeutics Limited
Tel. +44 1635576298
E-mail: info@proteontx.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|